Based on the research and analyses presented here, it appears that cerebral ischemia is an event that triggers the amyloidogenic processing of the APP, the products of which, in particular amyloid, are involved in the amyloidogenic phenomenon and irreversible damage to neurons post-ischemia (Figure 1). The gene discussed is APP; the disease is ischemia.